Related posts
Stocks across the board rally on optimismInstead of buying a single vaccine-making pharma, consider this. They have an established vaccine business and are working on plasma-based treatments for Covid. They also have a big contract manufacturing business of vaccines with JNJ, AZN and Novavax. This has fallen $40 from its August peak. But last night they issued bullish future numbers for this year, and the stock jumped 4.7% today. More upside to come.
Emergent BioSolutions is a American stock, trading under the symbol EBS-N on the New York Stock Exchange (EBS). It is usually referred to as NYSE:EBS or EBS-N
In the last year, there was no coverage of Emergent BioSolutions published on Stockchase.
Emergent BioSolutions was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Emergent BioSolutions .
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Emergent BioSolutions In the last year. It is a trending stock that is worth watching.
On 2024-10-11, Emergent BioSolutions (EBS-N) stock closed at a price of $8.75.
A disaster. He feels bad for J&J that they ever signed a contract with them.